Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Roivant Sciences Ltd shares valued at $1,172,120 were purchased by Venker Eric on Aug 20 ’25. At $11.72 per share, Venker Eric acquired 100,000 shares.
Also, Venker Eric sold 100,000 shares, netting a total of over 1,152,000 in proceeds. Following the sale of shares at $11.52 each, the insider now holds 1,462,223 shares.
Before that, Venker Eric had added 100,000 shares to its account. In a trade valued at $1,151,942, the Officer bought Roivant Sciences Ltd shares for $11.52 each.
Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid February. As of January 05, 2024, Piper Sandler has initiated its “an Overweight” rating for ROIV. Earlier on December 12, 2023, Deutsche Bank initiated its rating. Their recommendation was “a Buy” for ROIV stock.
Analyzing ROIV Stock Performance
On last trading session, Roivant Sciences Ltd [NASDAQ: ROIV] rose 0.77% to $11.81. The stock’s lowest price that day was $11.54, but it reached a high of $11.82 in the same session. During the last five days, there has been a surge of approximately 0.51%. Over the course of the year, Roivant Sciences Ltd shares have jumped approximately 2.79%. Shares of the company reached a 52-week high of $12.20 on 01/02/25 and a 52-week low of $8.73 on 04/07/25.
Support And Resistance Levels for Roivant Sciences Ltd (ROIV)
According to the 24-hour chart, there is a support level at 11.63, which, if violated, would cause prices to drop to 11.44. In the upper region, resistance lies at 11.91. The next price resistance is at 12.00. RSI (Relative Strength Index) is 56.72 on the 14-day chart, showing neutral technical sentiment.
Is Roivant Sciences Ltd subject to short interest?
Stocks of Roivant Sciences Ltd saw a sharp steep in short interest on 2025-07-31 dropping by -2.79 million shares to 38.31 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 41.1 million shares. A decline of -7.27% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 6.62 of the overall float, the days-to-cover ratio (short ratio) decline to 6.62.
Which companies own the most shares of Roivant Sciences Ltd (ROIV)?
In terms of Roivant Sciences Ltd share price expectations, FactSet research, analysts set an average price target of 17 in the next 12 months, up nearly 45.05% from the previous closing price of $11.72. Analysts anticipate Roivant Sciences Ltd stock to reach 20 by 2025, with the lowest price target being 12.5. In spite of this, 7 analysts ranked Roivant Sciences Ltd stock as Buy at the end of 2025. On October 17, 2023, Guggenheim assigned a price target of “a Buy” to the stock and initiated coverage with a $17.
